Background Persistent infection by oncogenic human papillomavirus (HPV) is necessary
although not sufficient for development of cervical cancer. Behavioural, environmental, or …

Epstein–Barr virus (EBV) is one of eight known herpesviruses with the potential to infect
humans. Globally, it is estimated that between 90–95% of the population has been infected …

Background Uterine Cervical Carcinoma (UCC) is the most prevalent gynecological
malignancy globally, with a rising incidence in recent years. Accumulating evidence …

Background This study aimed to evaluate the possible role of human papillomavirus (HPV)
and Epstein–Barr virus (EBV) coinfection as an etiological factor for prostate cancer (PCa) …

Epstein-Barr virus (EBV) is a well-characterized oncovirus, associated with several
malignancies. The complex and heterogeneous nature of colorectal cancer (CRC) has led to …

Gliomas are the most common malignant brain tumors and account for around 60% of all
primary central nervous system cancers. Glioblastoma multiforme (GBM) is a grade IV …

Oncoviruses are implicated in around 20% of all human cancers including both solid and
non-solid malignancies. Epstein–Barr virus (EBV) and human papillomaviruses (HPVs) are …

Epstein–Barr virus (EBV) belongs to the group of gamma-herpes viruses and was the first
recognized human oncovirus. EBV is responsible for infectious mononucleosis and multiple …

High‐risk human papillomaviruses (HR‐HPVs) cause various malignancies in the
anogenital and oropharyngeal regions. About 70% of cervical and oropharyngeal cancers …

Human papillomaviruses (HPVs) and the Epstein–Barr virus (EBV) are the most common
oncoviruses, contributing to approximately 10%–15% of all malignancies. Oncoproteins of …